| Model-based and model-free machine learning techniques for diagnostic prediction and classification of clinical outcomes in Parkinson’s disease C Gao, H Sun, T Wang, M Tang, NI Bohnen, MLTM Müller, T Herman, ... Scientific reports 8 (1), 7129, 2018 | 198 | 2018 |
| Predictive big data analytics: a study of Parkinson’s disease using large, complex, heterogeneous, incongruent, multi-source and incomplete observations ID Dinov, B Heavner, M Tang, G Glusman, K Chard, M Darcy, R Madduri, ... PloS one 11 (8), e0157077, 2016 | 154 | 2016 |
| Model-based and model-free techniques for amyotrophic lateral sclerosis diagnostic prediction and patient clustering M Tang, C Gao, SA Goutman, A Kalinin, B Mukherjee, Y Guan, ID Dinov Neuroinformatics 17, 407-421, 2019 | 40 | 2019 |
| Individualized adaptive radiation therapy allows for safe treatment of hepatocellular carcinoma in patients with Child-Turcotte-Pugh B liver disease WC Jackson, M Tang, C Maurino, M Mendiratta-Lala, ND Parikh, ... International Journal of Radiation Oncology* Biology* Physics 109 (1), 212-219, 2021 | 24 | 2021 |
| Biochemical failure is not a surrogate end point for overall survival in recurrent prostate cancer: analysis of NRG Oncology/RTOG 9601 WC Jackson, M Tang, MJ Schipper, HM Sandler, ZS Zumsteg, ... Journal of Clinical Oncology 40 (27), 3172-3179, 2022 | 20 | 2022 |
| Cardiac magnetic resonance imaging and blood biomarkers for evaluation of radiation-induced cardiotoxicity in patients with breast cancer: results of a phase 2 clinical trial C Speers, VL Murthy, EM Walker, CK Glide-Hurst, R Marsh, M Tang, ... International Journal of Radiation Oncology* Biology* Physics 112 (2), 417-425, 2022 | 13 | 2022 |
| The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity AD Burden, H Bachelez, SE Choon, S Marrakchi, TF Tsai, H Turki, ... British Journal of Dermatology 189 (1), 138-140, 2023 | 8 | 2023 |
| Dosimetric impact of interfractional organs at risk variation during high-dose rate interstitial brachytherapy for gynecologic malignancies PG Hawkins, M Tang, KA Vineberg, L Young, K Kovach, C Lee, ... Medical Dosimetry 44 (3), 239-244, 2019 | 3 | 2019 |
| Measuring GPPGA, Pain, Symptom, and Quality of Life Index Scores in Untreated Generalized Pustular Psoriasis: Results from the Placebo Group of the Effisayil-2 Trial B Strober, A Mostaghimi, M Anadkat, C Thoma, M Tang, J Guercio, ... SKIN The Journal of Cutaneous Medicine 8 (2), s361-s361, 2024 | 2 | 2024 |
| 33547 Validation of the Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) scale for assessing severity of GPP AD Burden, H Bachelez, SE Choon, S Marrakchi, TF Tsai, A Morita, ... Journal of the American Academy of Dermatology 87 (3), AB218, 2022 | 2 | 2022 |
| Cardiac MRI and blood biomarkers for evaluation of radiation-induced cardiotoxicity in breast cancer patients: results of a phase II clinical trial C Speers, VL Murthy, EM Walker, CK Glide-Hurst, R Marsh, M Tang Int J Radiat Oncol [Internet], 2021 | 2 | 2021 |
| Step‐adjusted tree‐based reinforcement learning for evaluating nested dynamic treatment regimes using test‐and‐treat observational data M Tang, L Wang, MA Gorin, JMG Taylor Statistics in medicine 40 (27), 6164-6177, 2021 | 1 | 2021 |
| Metastasis-Free Survival, but Not Biochemical Failure, is a Strong Surrogate Endpoint for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 WC Jackson, M Tang, M Schipper, HM Sandler, ZS Zumsteg, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), S63-S64, 2020 | 1 | 2020 |
| Spesolimab decreases generalized pustular psoriasis (GPP) body surface area (BSA) over time: Results from the EFFISAYIL® 2 trial B Strober, J Merola, A Gottlieb, A Mostaghimi, J Hsiao, J Guercio, M Tang, ... SKIN The Journal of Cutaneous Medicine 8 (6), s491-s491, 2024 | | 2024 |
| Spesolimab decreases generalized pustular psoriasis (GPP) body surface area (BSA) over time in patients switching from conventional systemic treatments: Results from the … J Merola, B Strober, A Gottlieb, A Mostaghimi, J Hawkes, J Guercio, ... SKIN The Journal of Cutaneous Medicine 8 (6), s488-s488, 2024 | | 2024 |
| Spesolimab decreases generalized pustular psoriasis (GPP) body surface area (BSA) over time in patients with various lengths of disease history: Results from the EFFISAYIL® 2 trial A Mostaghimi, B Strober, J Merola, A Gottlieb, B Elewski, J Guercio, ... SKIN The Journal of Cutaneous Medicine 8 (6), s489-s489, 2024 | | 2024 |
| Four-weekly dosing intervals with subcutaneous spesolimab appear to be required for optimal prevention of generalized pustular psoriasis flares: Data from the EFFISAYIL® 2 and … D Thaci, A Morita, B Strober, T Torres, A Pinter, A Marzano, J Krueger, ... SKIN The Journal of Cutaneous Medicine 8 (6), s492-s492, 2024 | | 2024 |
| Spesolimab increases the percentage of generalized pustular psoriasis (GPP) patients with clear skin over time as measured by the Physician’s Global Assessment for GPP (GPPGA … A Gottlieb, B Strober, J Merola, A Mostaghimi, A Farberg, J Guercio, ... SKIN The Journal of Cutaneous Medicine 8 (6), s490-s490, 2024 | | 2024 |
| 51782 Generalized pustular psoriasis (GPP) continues to adversely impact quality of life between flares, as per Dermatology Life Quality Index scores: Baseline data from the … M Augustin, AB Gottlieb, Y Tada, L Puig, B Elewski, M Gooderham, ... Journal of the American Academy of Dermatology 91 (3), AB220, 2024 | | 2024 |
| 51349 Spesolimab for the prevention of generalized pustular psoriasis (GPP) flares in White/Caucasian patients: Results from the randomized, placebo-controlled Effisayil 2 study B Strober, RB Warren, KB Gordon, RG Langley, MG Lebwohl, L Puig, ... Journal of the American Academy of Dermatology 91 (3), AB87, 2024 | | 2024 |
Matthew SchipperProfessor of Radiation Oncology and Biostatistics, University of MichiganVerified email at umich.edu